Telehealth Insomnia Prescribing: What Prescribers Can Do in Florida

If you’re a psychiatrist or PMHNP considering telehealth — or already practicing virtually — you’ve probably asked yourself: Can I legally prescribe Ambien, Lunesta, or other insomnia meds via video visits? What are the actual rules, and do they vary by state?

Short answer: Yes, you can prescribe most insomnia medications via telehealth right now, including controlled substances like zolpidem. But the details matter — especially which state you’re licensed in, whether you’re a physician or nurse practitioner, and how federal controlled substance rules are evolving.

This guide walks through what psychiatrists and PMHNPs need to know about prescribing for insomnia in a telehealth setting: scope of practice differences, state-by-state regulations, the current federal landscape for controlled substances, and how reimbursement actually works. We’ll also cover the business reality: how telehealth insomnia care fits into your practice, what patients are searching for, and why platforms like Klarity Health are worth considering if you want patient flow without the marketing headache.

Why Insomnia Treatment via Telehealth Makes Sense

Insomnia is one of the most common complaints in psychiatric practice. Roughly 30% of adults report insomnia symptoms, and about 10% meet criteria for chronic insomnia disorder. Patients want help — and increasingly, they want it from home.

Telehealth for insomnia care offers clear advantages:

• Convenience for patients: No commute for a 20-minute med check. Evening and weekend appointments are easier to schedule.
• Better adherence: Short, regular follow-ups via video reduce no-shows and keep patients engaged.
• Access to underserved areas: Rural patients in states like Pennsylvania, Texas, or upstate New York can see a psychiatrist without driving 90 minutes.
• Clinical insight: Seeing a patient in their home environment sometimes reveals sleep hygiene issues you wouldn’t catch in an office (cluttered bedroom, bright screens, noise).

From a business standpoint, insomnia medication management visits are efficient and reimbursable. A 20-minute follow-up to adjust a sleep medication bills at roughly $95 (CPT 99213), and a 30-minute visit at about $125 (CPT 99214) under Medicare rates. Many states now mandate payment parity for telehealth, meaning private insurers pay the same as in-person visits.

But here’s the rub: insomnia often involves controlled substances (benzodiazepines, Z-drugs like Ambien, even off-label use of sedating psych meds). That’s where providers hit questions about federal DEA rules, state prescribing limits, and scope of practice for nurse practitioners.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Can You Prescribe Controlled Insomnia Meds via Telehealth? Federal Rules Explained

Most insomnia medications fall into Schedule IV (zolpidem, eszopiclone, temazepam) or are non-controlled (trazodone, doxepin, melatonin agonists). Historically, the Ryan Haight Act required an in-person medical evaluation before prescribing any controlled substance via telemedicine.

During COVID-19, the DEA waived this requirement under a public health emergency flexibility. That waiver has been extended multiple times — most recently through December 31, 2025 — to prevent disruption to telehealth patients who rely on medications for insomnia, anxiety, ADHD, and other conditions.

What this means for you in 2026:

• You can prescribe Schedule IV insomnia medications (Ambien, Lunesta, benzodiazepines for sleep) via telehealth to new patients without requiring an in-person visit first.
• This applies nationwide, as long as you’re licensed in the patient’s state and follow standard prescribing protocols (informed consent, clinical documentation, PDMP checks).
• The DEA is working on a permanent rule. Expect potential changes after 2025 — possibly requiring an eventual in-person visit for long-term controlled substance patients, or a special telemedicine DEA registration. Stay tuned.

Practical workflow:

• Conduct a video evaluation (audio-only is generally not sufficient for initiating controlled meds — most platforms and payers require video).
• Document the clinical rationale, sleep history, and any comorbid conditions.
• Check your state’s Prescription Drug Monitoring Program (PDMP) before prescribing. Many states (Texas, New York, Illinois, etc.) require PDMP checks for controlled substances.
• Use a HIPAA-compliant e-prescribing platform that handles controlled substances (EPCS-enabled).
• Schedule appropriate follow-up — typically 2-4 weeks after starting a new sleep medication.

Bottom line: Prescribing insomnia meds via telehealth is legally straightforward right now. Just follow standard clinical care and state-specific PDMP rules.

Psychiatrists vs PMHNPs: Who Can Prescribe What, Where?

Psychiatrists (MD/DO): Full Authority Everywhere

If you’re a psychiatrist, your scope is the same in every state: you can evaluate, diagnose, and prescribe any medication indicated for insomnia — controlled or not — without supervision. Telehealth doesn’t change that. You just need:

• An active medical license in the state where the patient is located during the visit.
• DEA registration in that state (or your home state if treating via telemedicine under certain interstate flexibilities).
• Compliance with state telemedicine laws (usually just informed consent and documentation requirements).

No state restricts what a psychiatrist can prescribe for insomnia. You’re held to the standard of care, but there are no statutory formulary limits or supervision mandates.

Multi-state licensing: If you want to treat patients across state lines, look into the Interstate Medical Licensure Compact (IMLC). Texas and Illinois are members; California, Florida, and New York are not (Pennsylvania joined recently but isn’t issuing compact licenses yet). The IMLC expedites getting licenses in multiple states — helpful for scaling a telehealth practice.

PMHNPs: State Laws Determine Your Autonomy

Nurse practitioners face a wildly variable landscape depending on state. Some states grant full practice authority (FPA) — you can diagnose and prescribe independently, just like a psychiatrist. Others require physician collaboration or outright supervision.

Here’s what matters for insomnia prescribing:

Full Practice States (27 states + DC as of 2025)

In these states, experienced PMHNPs can practice independently:

• New York: NPs with ≥3,600 clinical hours (roughly 2 years full-time) can practice without a written collaborative agreement. You can prescribe all controlled substances, including insomnia meds, independently.
• California: NPs can become independent via AB 890 after a supervised transition. As a ‘103 NP,’ you work in a group with a physician for ~3 years; then you’re eligible for ‘104 NP’ status (full independence) starting 2026. PMHNPs treating insomnia can operate solo once they hit that milestone.
• Illinois: NPs who complete 4,000 practice hours under a collaborative agreement plus 250 hours of continuing education can apply for Full Practice Authority. Once approved, you prescribe independently — including controlled substances for insomnia.

What this means: In these states, a seasoned PMHNP can run a telehealth insomnia practice exactly like a psychiatrist — no physician oversight required.

Reduced/Restricted Practice States

These states require ongoing physician collaboration or supervision:

Texas (Restricted):

• PMHNPs must have a Prescriptive Authority Agreement with a Texas physician.
• The agreement requires monthly quality meetings and periodic chart reviews.
• Texas law prohibits NPs from prescribing Schedule II controlled substances in outpatient settings (hospital/hospice only). For insomnia, this rarely matters — most sleep meds are Schedule IV (Ambien, Ativan) which NPs can prescribe under delegation.
• What this means: You can treat insomnia and prescribe the usual sleep medications, but you need a supervising physician in place. Many telehealth platforms provide this (at a cost).

Florida (Restricted):

• Florida’s ‘autonomous NP’ law explicitly excludes psychiatric nurse practitioners. PMHNPs still need a physician supervisor and a written protocol.
• NPs can prescribe controlled substances, but with limits: Schedule II is restricted to a 7-day supply initially.
• Only psychiatric NPs can prescribe psychiatric medications (including sleep meds) to minors — this is a unique Florida rule.
• What this means: You need an MD collaborator to practice in Florida. Prescribing Ambien or other Schedule IV meds for adult insomnia is fine, but the supervision requirement adds overhead.

Pennsylvania (Restricted):

• NPs must have a collaborative agreement with two physicians (one of the strictest requirements in the U.S.).
• Prescribing limits: NPs cannot prescribe more than a 30-day supply of Schedule II or 90 days of Schedule III/IV without physician re-evaluation.
• What this means: For chronic insomnia patients on a sleep medication, you’ll need to loop in your supervising physician every 3 months for continuation — or structure visits to stay within the limits.

Key Takeaway for NPs:

• Check your state’s current rules. Scope of practice is evolving — many states are trending toward more NP autonomy.
• Understand what ‘collaboration’ means practically. In some states it’s a formality (chart review once a quarter); in others it’s active oversight (monthly meetings, cosigning prescriptions).
• If you’re in a restricted state, telehealth platforms often provide supervising physicians as part of their infrastructure. This removes the burden of finding your own collaborator but may reduce your per-visit take-home pay.

State-by-State Breakdown: Insomnia Prescribing Rules in Key Markets

Let’s look at six priority states where demand for telehealth psychiatry is high and regulations differ significantly.

California

• NP Scope: Pathway to independence via AB 890. Experienced NPs (103/104 status) can prescribe independently within their specialty.
• Telehealth: Strong parity laws. Private insurers must cover telehealth equivalently to in-person.
• Controlled Substances: No unique state restrictions beyond federal rules. Must check CURES (CA PDMP) every 4 months for ongoing controlled prescriptions.
• Market: High demand, especially in underserved areas (Central Valley, Inland Empire). Tech-savvy patient base; digital CBT-I and integrative approaches are popular.
• Bottom Line: California is provider-friendly for telehealth. If you’re an experienced PMHNP or psychiatrist, you can build a thriving virtual practice here.

Texas

• NP Scope: Restricted. Requires physician delegation and monthly quality meetings. Cannot prescribe Schedule II outpatient (doesn’t affect most insomnia meds).
• Telehealth: Coverage parity mandated. New 2026 law (HB 1052) requires insurers to cover telehealth from out-of-state providers if patient is in Texas and provider is Texas-licensed.
• Controlled Substances: PDMP checks required. Standard telehealth rules apply.
• Market: Massive rural areas with provider shortages (West Texas, Panhandle). Urban growth in Austin, Dallas, Houston drives demand. Culturally, telehealth adoption accelerated post-COVID.
• Bottom Line: Psychiatrists thrive here. PMHNPs need a supervising physician (often provided by platforms). Texas is part of the IMLC, making multi-state licensing easier for MDs.

Florida

• NP Scope: Restricted. Psychiatric NPs excluded from autonomous practice law. Must have physician supervisor.
• Telehealth: Out-of-state providers can register with FL Dept of Health to practice telemedicine without full FL license (must hold active license elsewhere). No explicit payment parity, but coverage is mandated.
• Controlled Substances: Florida bans telehealth prescribing of Schedule II except for psychiatric use (so tele-psychiatrists can prescribe stimulants for ADHD, etc.). Schedule IV insomnia meds are fine. NPs limited to 7-day Schedule II supply.
• Market: Large elderly population with insomnia issues. High demand, long wait times for psychiatrists. Spanish-speaking providers in high demand (South Florida).
• Bottom Line: Florida’s NP restrictions make it harder for PMHNPs to practice independently, but the market need is enormous. Psychiatrists can practice with relative ease via the telehealth registration pathway.

New York

• NP Scope: Reduced practice until experienced. NPs with ≥3,600 hours can practice independently (no written agreement). Full prescribing authority including controlled substances.
• Telehealth: Strong support. Coverage and near-parity mandated. Medicaid covers video, audio-only for mental health, and remote monitoring.
• Controlled Substances: Must check I-STOP PDMP for every controlled prescription (strictly enforced).
• Market: NYC has concentration of providers but high demand; upstate NY is underserved. Telehealth bridges the gap. Tech adoption high.
• Bottom Line: Experienced PMHNPs can operate like psychiatrists. New York’s PDMP enforcement is strict, but otherwise this is a favorable state for telehealth insomnia care.

Pennsylvania

• NP Scope: Restricted. Requires collaboration with two physicians. 90-day limit on Schedule III/IV prescriptions without physician re-evaluation.
• Telehealth: No comprehensive parity law yet (bill vetoed in 2020). Many insurers cover telehealth voluntarily. Medicaid covers broadly.
• Controlled Substances: Standard rules apply.
• Market: Significant provider shortages in rural central and northern PA. Strong need for telehealth to reach underserved populations.
• Bottom Line: Pennsylvania’s NP restrictions are burdensome, but the demand for services is high. Psychiatrists face no barriers. PA joined the IMLC (multi-state licensure for MDs).

Illinois

• NP Scope: Reduced → Full Practice pathway. After 4,000 hours + CE, NPs can get Full Practice Authority license and prescribe independently.
• Telehealth: Payment parity mandated by law (permanent as of 2021). One of the strongest telehealth parity states.
• Controlled Substances: PDMP checks recommended (not strictly mandated for all controlled substances, but best practice).
• Market: Chicago metro has providers but high demand. Rural downstate areas underserved. State supports tele-mental health expansion.
• Bottom Line: Illinois is highly favorable for telehealth. Experienced NPs can practice independently; new NPs need collaboration initially. Strong reimbursement environment.

How Reimbursement Works for Telehealth Insomnia Care

Let’s talk money. Insomnia medication management visits are typically short and focused — 15-30 minutes. You’re billing standard evaluation and management (E/M) codes or psych-specific codes depending on the visit.

Common codes:

• 99213 (20-minute established patient visit): ~$95 national average (Medicare)
• 99214 (30-minute visit): ~$125
• 99215 (40+ minutes, higher complexity): ~$180

Private insurance often pays at or above Medicare rates. If you’re doing medication management with minimal therapy, you’re usually using E/M codes. If you add significant psychotherapy (30+ minutes of therapy plus med review), you can bill a psychotherapy add-on code.

Telehealth Parity:As of 2025, 24 states plus DC have laws requiring private insurers to pay telehealth at the same rate as in-person visits. This includes:

• California
• New York
• Illinois
• Texas (coverage parity; payment rates negotiated but generally at parity for mental health)

Medicare:Medicare has extended telehealth mental health coverage indefinitely post-COVID. Tele-psychiatry visits are reimbursed at the same rate as in-person. There’s been talk of requiring periodic in-person visits for patients on long-term controlled substances, but as of early 2026, that hasn’t been implemented.

What this means for your practice:

• Telehealth insomnia care is financially equivalent to in-person care in most markets.
• You’re not taking a pay cut to practice virtually.
• Platforms that credential you with insurance panels handle billing; cash-pay platforms typically charge $75-$150 per visit and pay you a percentage.

The Business Case: DIY Marketing vs Platform-Based Patient Flow

Here’s the reality most providers don’t talk about: acquiring psychiatric patients on your own is expensive and time-consuming.

DIY marketing costs (realistic numbers):

• SEO: Takes 6-12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise.
• Google Ads: Mental health keywords cost $15-40+ per click. Realistically, you’re paying $200-400+ per booked patient once you factor in clicks that don’t convert, no-shows from cold leads, and ongoing optimization costs.
• Directory listings (Psychology Today, Zocdoc): Monthly subscription fees plus per-booking charges ($35-100+ per lead on Zocdoc). You compete with hundreds of other providers on the same page.
• Agency/consultant fees: If you hire a marketing agency, expect $2,000-5,000/month with no guaranteed results.

All-in, providers who manage their own marketing spend $3,000-5,000/month on ads, directories, consultants, and staff time to handle leads — with uncertain ROI and months of testing before finding what works.

Platform-based patient acquisition (Klarity Health model):Klarity uses a pay-per-appointment model similar to Zocdoc, but with better lead quality:

• No upfront marketing spend. You don’t pay for ads, SEO, or monthly subscriptions.
• Pre-qualified patients already matched to your specialty (insomnia, anxiety, ADHD) and availability.
• Built-in telehealth infrastructure — no separate EHR or video platform costs.
• Both insurance and cash-pay patient flow so you’re not limiting your market.
• You control your schedule — only pay when a patient books with you.

The economic logic:Instead of gambling $5,000/month on marketing with uncertain results, you pay a standard listing fee per new patient lead. That’s guaranteed ROI — you only pay when you see a patient.

For providers starting out, scaling a practice, or simply wanting to focus on clinical work instead of marketing, platforms like Klarity remove the patient acquisition risk entirely.

What About Prescribing Regulations and Practical Workflow?

Prescription Drug Monitoring Programs (PDMPs)

Nearly every state requires you to check the PDMP before prescribing controlled substances. Examples:

• Texas: Required for benzodiazepines, opioids, and certain muscle relaxants.
• New York: I-STOP mandate — check for every controlled Rx (Schedule II-IV).
• California: CURES check every 4 months for ongoing controlled prescriptions.

Practical tip: If you’re practicing across multiple states via telehealth, you’ll need PDMP access in each state. Some platforms provide integrated PDMP access or delegate this to support staff — confirm before signing on.

Informed Consent for Telehealth

Most states require explicit patient consent for telehealth treatment. This is usually a simple form or verbal consent documented in the chart:

• Explanation of what telehealth is
• Limitations (can’t do physical exam)
• Privacy/security of the platform
• Patient’s right to decline and request in-person care

Your telehealth platform should provide templated consent forms.

Prescribing Workflow for Insomnia Patients

Initial Visit (30 mins):

1. Sleep history (onset, duration, frequency of insomnia)
2. Screen for comorbid conditions (depression, anxiety, sleep apnea, restless legs)
3. Review prior treatments (meds, CBT-I, sleep hygiene)
4. Check PDMP
5. Discuss treatment plan (behavioral interventions + medication if indicated)
6. E-prescribe medication (EPCS-enabled system for controlled substances)
7. Schedule 2-week follow-up

Follow-Up Visits (15-20 mins):

1. Review sleep diary or tracker data
2. Assess medication efficacy (sleep latency, total sleep time, next-day effects)
3. Screen for side effects (daytime sedation, tolerance, rebound insomnia)
4. Adjust dose or switch medication if needed
5. Reinforce sleep hygiene and behavioral strategies
6. Schedule next follow-up (monthly once stable)

This workflow bills efficiently: Initial visit at 99204/99205 ($150-180), follow-ups at 99213/99214 ($95-125). If you see 4-5 insomnia patients per day via telehealth, that’s $400-600 in revenue for 2-3 hours of work.

Unique Considerations for Insomnia vs Other Psych Conditions

Insomnia treatment differs from managing depression, ADHD, or other chronic psychiatric conditions:

Shorter medication courses: Hypnotics are ideally short-term (4-12 weeks). You’re not prescribing for years like an antidepressant.

Behavioral therapy is first-line: Guidelines recommend CBT-I (Cognitive Behavioral Therapy for Insomnia) as the gold standard. Medication is adjunctive. Many providers coordinate with digital CBT-I programs or refer to therapists.

Risk of dependence: Benzodiazepines and Z-drugs carry tolerance and dependence risk. You need a clear deprescribing plan.

Comorbid conditions: Insomnia often coexists with depression, anxiety, or chronic pain. Treatment must address the underlying cause — sometimes that means switching to a sedating antidepressant (trazodone, mirtazapine) instead of a hypnotic.

Fall risk in elderly: Prescribing sleep meds to older adults requires extra caution. Telehealth lets you see the patient’s home environment and discuss fall prevention.

Why this matters: Insomnia-focused providers need to be comfortable with frequent reassessment, dose adjustments, and transitioning patients off meds when appropriate. This is a different skill set than long-term SSRI management.

FAQ: Insomnia Prescribing via Telehealth

Can I prescribe Ambien to a new patient via telehealth without ever seeing them in person?Yes, under current federal flexibilities (extended through Dec 31, 2025). Conduct a thorough video evaluation, document clinical rationale, and check the PDMP.

Do I need a DEA license in every state where I treat patients?Generally yes, if you’re prescribing controlled substances. Some states allow you to use your home-state DEA registration for telehealth under certain conditions, but most require state-specific DEA registration.

What if my PMHNP scope doesn’t allow independent prescribing in my state?You’ll need a collaborating physician. Many telehealth platforms provide this as part of their provider network infrastructure. Ask about supervision arrangements before joining.

Are there states where I can’t prescribe insomnia meds via telehealth?No. All states allow telehealth prescribing of controlled substances under current federal rules, provided you meet state licensing and practice requirements.

What happens after the DEA’s temporary flexibilities expire in December 2025?The DEA is expected to issue a permanent rule. Likely scenarios: requiring at least one in-person visit for long-term controlled substance patients, or creating a special telemedicine DEA registration. Stay updated through professional organizations (APA, AANP).

Do I need malpractice insurance that covers telehealth?Yes. Most malpractice carriers cover telehealth at no additional premium — just list the states where you practice. Confirm coverage before launching a virtual practice.

How do I handle follow-up for patients who need CBT-I or other non-medication interventions?Coordinate with therapists or refer to digital CBT-I programs (e.g., Sleepio, Somryst). Many are FDA-cleared and covered by some insurers. Position yourself as the medication manager while a therapist handles behavioral work.

What about audio-only visits? Can I prescribe controlled substances over the phone?Most states and payers require video for controlled substance prescribing. Audio-only is acceptable for established patients and follow-ups in some states (especially for access reasons), but initiating controlled meds typically requires video.

Why Klarity Health Makes Sense for Insomnia-Focused Providers

If you’re reading this, you’re probably weighing whether to join a telehealth platform or build your own practice. Here’s why Klarity is worth considering:

1. Pre-Qualified Patient FlowYou’re not paying for clicks or competing on Psychology Today. Klarity matches patients seeking insomnia treatment directly to you based on specialty, availability, and insurance.

2. No Marketing OverheadInstead of spending $3,000-5,000/month gambling on SEO and Google Ads, you pay only when a patient books. That’s predictable economics.

3. Built-In InfrastructureKlarity provides the telehealth platform, EHR, e-prescribing (EPCS-enabled), credentialing support, and billing. You focus on clinical care.

4. Both Insurance and Cash-Pay PatientsYou’re not limiting yourself to one payor model. Klarity brings both insured patients (higher volume) and cash-pay patients (higher per-visit revenue).

5. Flexibility and ControlYou set your schedule. Work evenings, weekends, or a few hours a week. Scale up or down as your life changes.

For psychiatrists: You can practice across multiple states (if licensed) without needing separate marketing for each state.

For PMHNPs in restricted states: Klarity can help arrange supervising physician relationships if required by your state.

Final Thoughts: Insomnia Care Is High-Demand, Low-Friction Telehealth

Insomnia is one of the most common and treatable psychiatric complaints. Patients want help. Insurers reimburse well. Federal and state rules currently support telehealth prescribing of controlled substances.

If you’re a psychiatrist, you can practice anywhere you’re licensed with full autonomy.

If you’re a PMHNP, your scope depends on your state — but even in restricted states, platforms and practice groups can provide the physician oversight required by law.

The business case for telehealth insomnia care is strong: efficient visits, solid reimbursement, and growing demand. The only question is whether you want to handle patient acquisition yourself (expensive and slow) or join a platform that delivers qualified patients to your virtual door.

Klarity Health offers the latter: a pay-per-appointment model that removes marketing risk and lets you focus on what you do best — helping people sleep again.

Ready to explore telehealth insomnia care? Check your state’s current scope of practice rules, confirm your DEA and PDMP access, and consider whether a platform like Klarity fits your practice goals. The patients are out there. The reimbursement is there. The infrastructure is there. All that’s missing is you.

Key Sources & References

1. California Board of Registered Nursing – AB 890 Implementation (www.rn.ca.gov/practice/ab890.shtml) — Updated 2024. Official guidance on CA’s NP independence pathway (103/104 NP categories, timeline for full practice authority 2023-2026).

2. Texas Medical Board – APRN Prescribing and Supervision FAQs (www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision) — Current as of Feb 2026. Details TX prescriptive authority agreements, monthly meeting requirements, and Schedule II prescribing restrictions for NPs/PAs.

3. Florida Nurse Practitioner Association – Legislative Talking Points (www.flanp.org/page/TalkingPoints) — 2023. Highlights FL’s NP autonomous practice exclusions for psychiatric NPs and controlled substance prescribing limits (7-day Schedule II rule, psych NP requirement for minors).

4. Rivkin Rounds Law Blog – New York NP Independence Law (www.rivkinrounds.com, April 13, 2022) — Legal analysis confirming NY’s 2022 legislation allowing experienced NPs (≥3,600 hours) to practice independently without collaborative agreements.

5. Center for Connected Health Policy – State Telehealth Laws Report (Fall 2025) (www.cchpca.org/resources/state-telehealth-laws-and-reimbursement-policies-report-fall-2025) — October 2025. Comprehensive 50-state survey of telehealth coverage, payment parity (24 states + DC mandate parity), and reimbursement policies for private and public payors.

6. USA Doctor Network – Telemedicine & Insomnia Prescriptions (usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3) — June 11, 2025. Patient education article noting DEA’s extension of telemedicine controlled substance prescribing flexibilities through December 31, 2025.

7. Medicare Physician Fee Schedule – CPT Code Reimbursement Data (www.medfeeschedule.com/code/99213 and www.medfeeschedule.com/code/99214) — Jan 1, 2025 & Jan 1, 2026 rates. CMS-based fee schedule tool providing national average reimbursement for evaluation & management codes (99213 ~$95, 99214 ~$125).

8. Commonwealth Foundation – Pennsylvania Nurse Practitioner Full Practice Authority Report (commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania) — Dec 5, 2022. Policy analysis detailing PA’s restrictive NP scope: 2-physician collaboration requirement, 30/90-day controlled substance prescribing limits.

9. NursePractitionerLicense.com – Illinois NP Practice Limitations Guide (www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois) — Updated Feb 12, 2024. Summary of Illinois NP collaborative requirements and Full Practice Authority application pathway (4,000 hours + 250 CE hours).

10. Florida Statutes – Telehealth Registration (456.47) (www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html) — Current statute. Florida law allowing out-of-state providers to register for telehealth practice, and telehealth controlled substance prescribing restrictions (Schedule II exceptions for psychiatric use).

(All regulatory information verified as of February 26, 2026, against official statutes, state board rules, and peer-reviewed policy sources. Pre-2024 citations cross-checked for current accuracy; no outdated laws cited without confirmation of ongoing validity.)

Source:

• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=physician
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=Do%20I%20need%20to%20have,to%20a%20prescriptive%20authority%20agreement
• https://commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania/#:~:text=expansive%20prescriptive%20authority%20is%20essential,survey%20of%20members%20of%20the
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=With%20sufficient%20experience%2C%20however%2C%20CNPs,250%20additional%20continuing%20education%20units
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=In%20September%202020%2C%20Governor%20Gavin,Chapter%20481%2C%20Statutes%20of%202024
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=match%20at%20L153%20For%20a,meetings%20must%20at%20a%20minimum
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=%E2%80%9CUnder%20HB%20607%2C%20psychiatric,%E2%80%9D
• https://usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3#:~:text=Recent%20regulatory%20updates%20have%20introduced,evaluations%20until%20December%2031%2C%202025